Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05351255 · ClinicalTrials.gov registry record · NA
Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex
A NA study of Cerebellar Ataxia, sponsored by Albert Einstein Healthcare Network.
- Active
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT05351255: Active NA study of Cerebellar Ataxia, sponsored by Albert Einstein Healthcare Network.
NCT05351255 is a NA study of Cerebellar Ataxia that is active but no longer recruiting, run by Albert Einstein Healthcare Network. The registered enrollment target is 17 participants, below the 348-participant average among 5 other Cerebellar Ataxia trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05351255, a NA study of Cerebellar Ataxia, is active but no longer recruiting, sponsored by Albert Einstein Healthcare Network.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine (1) whether baseline inhibitory activity in the primary motor cortex can predict motor learning ability in individuals with cerebellar degeneration, and (2) whether modulating primary motor cortex activity with non-invasive brain stimulation alters motor learning ability in this population.
Primary Outcome
The sore out of 100 that results from assessment using the International Cooperative Ataxia Rating Scale (ICARS). The rating scale has a minimum score of 0 and a maximum score of 100. Higher scores indicate more severe impairment.
Conditions Studied
Interventions
- DEVICE Transcranial Magnetic Stimulation (TMS)
Study Locations (1)
Pennsylvania
- Moss Rehabilitation Research Institute - Elkins Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2026-12-19 |
| Phase | NA |
What the registry record for NCT05351255 still lists
NCT05351255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 348-participant average among 5 other Cerebellar Ataxia trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Cerebellar Ataxia appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT05351255 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05351255 about?
NCT05351255 is a clinical study titled "Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex". This study will determine (1) whether baseline inhibitory activity in the primary motor cortex can predict motor learning ability in individuals with cerebellar degeneration, and (2) whether modulating primary motor cortex activity with non-invasive brain stimulation alters motor learning ability in...
What is the current status of trial NCT05351255?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2022-07-01. Estimated completion is 2026-12-19.
What conditions does trial NCT05351255 study?
This clinical trial studies the following conditions: Cerebellar Ataxia.
What interventions are being tested in trial NCT05351255?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE).
Who is sponsoring clinical trial NCT05351255?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05351255 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebellar Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Exercise for Individuals with Neurodegenerative Disease
RECRUITING · NA
-
Retraining Reaching in Cerebellar Ataxia
RECRUITING · NA
-
The Role of Cerebellum in Speech
ACTIVE NOT RECRUITING · NA
-
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
RECRUITING
-
Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI